Skip to Content

Exelon

In the US, Exelon (rivastigmine systemic) is a member of the drug class cholinesterase inhibitors and is used to treat Alzheimer's Disease and Parkinson's Disease.

US matches:

UK matches:

Ingredient matches for Exelon

Rivastigmine

Rivastigmine is reported as an ingredient of Exelon in the following countries:

  • Australia
  • Austria
  • Bosnia & Herzegowina
  • Canada
  • Chile
  • Croatia (Hrvatska)
  • Cyprus
  • Egypt
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Israel
  • Japan
  • Lebanon
  • Malaysia
  • Mexico
  • New Zealand
  • Norway
  • Oman
  • Peru
  • Philippines
  • Romania
  • Russian Federation
  • Sweden
  • Switzerland
  • Tunisia
  • Turkey
  • United Kingdom

Rivastigmine tartrate (a derivative of Rivastigmine) is reported as an ingredient of Exelon in the following countries:

  • Argentina
  • Australia
  • Austria
  • Bangladesh
  • Belgium
  • Brazil
  • Canada
  • China
  • Colombia
  • Czech Republic
  • Denmark
  • Ecuador
  • Finland
  • France
  • Hong Kong
  • Hungary
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Lithuania
  • New Zealand
  • Norway
  • Oman
  • Philippines
  • Poland
  • Portugal
  • Serbia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Switzerland
  • Taiwan
  • Thailand
  • United Kingdom
  • United States
  • Venezuela

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide